Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 23%
Hold 38%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co is poised for continued growth and we expect this trend to continue both organically and through strategic acquisitions. They have demonstrated strong demand in the behavioral health sector and have implemented measures to ensure the safety of their patients, employees and communities during the pandemic. Although they face some risks, we believe the company's focus on operational improvement and capital discipline justifies a premium valuation, leading us to maintain our buy rating and increase our target price to $31.

Bears say

Acadia Healthcare Co is facing several fundamental challenges that are likely to have a negative impact on its stock. These include soft CTC growth, specialty revenue decline, ongoing payor denials and reorganization efforts, which could lead to higher costs and lower profitability. Additionally, there are risks associated with potential government investigations and exposure to vulnerable patients. Despite some positive aspects, such as strong same-facility admissions and a diversified payor mix, it is difficult to have confidence in the company's stability based on current market trends.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 23% recommend Buy, 38% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $24.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $24.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.